Enikő Lázár, MD, PhD profile page

Enikő Lázár, MD, PhD earned her medical degree at Semmelweis University in Budapest, Hungary, where she also completed a PhD in Molecular Medicine at the Department of Physiology. Her doctoral work focused on the role of NADPH oxidases and heme peroxidases in redox regulation and tissue homeostasis. Following her PhD, she joined the Department of Cell and Molecular Biology at the Karolinska Institute in Stockholm, Sweden, as a postdoctoral researcher, where she investigated cell renewal dynamics in the human heart, liver, and skeletal muscle. She is currently a postdoctoral researcher at the Department of Gene Technology at KTH Royal Institute of Technology and SciLifeLab in Stockholm. In the lab of Prof. Joakim Lundeberg, she leads the research efforts utilizing spatial and single-cell omics technologies to study early human development, with a focus on healthy cardiogenesis and its disruption in congenital heart disease. In addition to her research, Dr. Lázár has served as scientific coordinator of the Swedish national consortium within the Human Developmental Cell Atlas and its follow-up project, the Atlas of Childhood Diseases, which investigates developmental and early-onset disorders using omics-based approaches. Her cardiogenesis-focused work has been recognized with the Swedish Medical Association’s Best Translational Project Prize (2025) and the Additional Ventures Travel Grant at the Weinstein Conference on Cardiovascular Development and Regeneration (2024). She is a member of the Swedish Developmental Biology Organization (SWEDBO) and the Global Alliance for Spatial Technologies (GESTALT), and has presented at major international conferences, including the 4th Spatial Biology Congress and 2nd International Cardiovascular Development, Anatomy and Regeneration Conference (2025), the Nordic Developmental Biology Societies’ Meeting (2024), and the British Cardiovascular Society’s Annual Conference (2023).